Novel insights into the biology of interleukin-32. (Q38086768)

28 August 2017

Novel insights into the biology of interleukin-32. (English)

1 reference

28 August 2017

4

Charles A Dinarello

1 reference

28 August 2017

3

Mihai G Netea

1 reference

28 August 2017

1

Leo A B Joosten

1 reference

28 August 2017

Bas Heinhuis

2

1 reference

28 August 2017

6 March 2013

1 reference

28 August 2017

10

1 reference

Cellular and Molecular Life Sciences

inferred from page(s)

published in

1 reference

28 August 2017

70

1 reference

28 August 2017

20

1 reference

28 August 2017

3883-3892

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-013-1301-9

28 August 2017

0 references

cites work

Involvement of IL-32 in activation-induced cell death in T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Identification of the most active interleukin-32 isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

NOD2 triggers an interleukin-32-dependent human dendritic cell program in leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Endogenous IL-32 controls cytokine and HIV-1 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Increased interleukin-32 expression in chronic hepatitis B virus-infected liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Protection from RNA and DNA viruses by IL-32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Characterizing antiviral mechanism of interleukin-32 and a circulating soluble isoform in viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Plasticity and virus specificity of the airway epithelial cell immune response during respiratory virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32 expression in the airway epithelial cells of patients with Mycobacterium avium complex lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32 is a host protective cytokine against Mycobacterium tuberculosis in differentiated THP-1 human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32 positively regulates radiation-induced vascular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Molecular characterization of IL-32 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Regulation and expression of IL-32 in chronic rhinosinusitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32 expression in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Alteration in the activation state of new inflammation-associated targets by phospholipase A2-activating protein (PLAA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Loss of microRNA-205 expression is associated with melanoma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Intracellular calcium level is upregulated by interleukin-32 in auditory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Proteinase 3 is an IL-32 binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Proteinase 3-processed form of the recombinant IL-32 separate domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Overview of integrin signaling in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Roles played by a subset of integrin signaling molecules in cadherin-based cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Focal adhesion kinase: in command and control of cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32-dependent effects of IL-1beta on endothelial cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Increased level of IL-32 during human immunodeficiency virus infection suppresses HIV replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Oxidative stress induced interleukin-32 mRNA expression in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32 induces the differentiation of monocytes into macrophage-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Suppressing IL-32 in monocytes impairs the induction of the proinflammatory cytokines TNFalpha and IL-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Anti-integrin monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Development of focal adhesion kinase inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

I-TASSER server for protein 3D structure prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Integrins and signal transduction

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

21 January 2018

12 December 2020

Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00018-013-1301-9

21 January 2018

12 December 2020

Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32alpha induction in human pancreatic periacinar myofibroblasts

1 reference

12 December 2020

Interleukin-32: a cytokine and inducer of TNFalpha

1 reference

12 December 2020

Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1

1 reference

12 December 2020

Identification of a novel gene expressed in activated natural killer cells and T cells

1 reference

12 December 2020

IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production

1 reference

12 December 2020

Tumor necrosis factor alpha-induced interleukin-32 is positively regulated via the Syk/protein kinase Cdelta/JNK pathway in rheumatoid synovial fibroblasts

1 reference

12 December 2020

New Lives Given by Cell Death: Macrophage Differentiation Following Their Encounter with Apoptotic Leukocytes during the Resolution of Inflammation

1 reference

12 December 2020

MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A

1 reference

12 December 2020

Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype

1 reference

12 December 2020

Effect of interleukin-32gamma on differentiation of osteoclasts from CD14+ monocytes

1 reference

12 December 2020

10.1007/S00018-013-1301-9

Identifiers

DOI

1 reference

28 August 2017

1 reference

PubMed ID

23463238